Hangzhou Kang Sheng Health Management Consulting Co., a Chinese firm offering diabetes management equipment, has completed a US$100 million series C financing round, totaling from a series C1 and C2 round, reported today by Chinese media 36kr. The series C2 round was led by CICC Capital and a health-focused fund of Chinese state-owned electricity firm […]

Chinese Diabetes Tracking Device Maker Raises Series C Round From CICC Capital appeared first on China Money Network.